跳至主要内容
临床试验/NCT06427577
NCT06427577招募中不适用

Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites

The First Affiliated Hospital with Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Visual Analog Score for pain

研究概览

简要总结

ZhenQi FuZheng granules has been used to improve the immune function of human body, protect the bone marrow and adrenal cortex function and promote the recovery of positive function in traditional Chinese medicine care, especially with the immune imbalance diseases like post-surgery, chemotherapy and rhinitis. This project intends to establish AR(allergic rhinitis)specimen library, cell and animal model experiment, combining clinical cohort research with applied basic research, further assess the therapeutic mechanism of ZhenQiFuZheng granules in AR. We assume that ZhenQi FuZheng granules could cause the metabolic omics changes of nasal inflammatory factors and nasal secretions in AR patients, thus improving the type 2 inflammation level of allergic rhinitis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18-65 years).
  • Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .

排除标准

  • Patients who refused to accept specimen and questionnaire collection.
  • Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.

研究组 & 干预措施

Allergic rhinitis

Experimental

ZhenQi FuZheng granules (ShiDaiYangGuang)

1 bag at a time, twice a day. Oral for 4 weeks.

干预措施: ZhenQi FuZheng granules (ShiDaiYangGuang) (Drug)

结局指标

主要结局

Visual Analog Score for pain

时间窗: 12 weeks

Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure

Rhinoconjunctivitis Quality of Life Questionnaire

时间窗: 12 weeks

Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验